Rochester Institute of Technology, Thomas H. Gosnell School of Life Sciences, Rochester, New York, USA.
Microbiol Spectr. 2024 Feb 6;12(2):e0350723. doi: 10.1128/spectrum.03507-23. Epub 2024 Jan 5.
Species within the genus are adept at sharing adaptive allelic variation, with commensal species repeatedly transferring resistance to their pathogenic relative . However, resistance in commensals is infrequently characterized, limiting our ability to predict novel and potentially transferable resistance mechanisms that ultimately may become important clinically. Unique evolutionary starting places of each species will have distinct genomic backgrounds, which may ultimately control the fate of evolving populations in response to selection as epistatic and additive interactions coerce lineages along divergent evolutionary trajectories. Alternatively, similar genetic content present across species due to shared ancestry may constrain existing adaptive solutions. Thus, identifying the paths to resistance across commensals may aid in characterizing the resistome-or the reservoir of alleles within the genus as well as its depth. Here, we use evolution of four commensal species to investigate the potential and repeatability of resistance evolution to two antimicrobials, the macrolide azithromycin and the β-lactam penicillin. After 20 days of selection, commensals evolved resistance to penicillin and azithromycin in 11/16 and 12/16 cases, respectively. Almost all cases of resistance emergence converged on mutations within ribosomal components or the efflux pump for azithromycin-based selection and , , and for penicillin selection, thus supporting constrained adaptive solutions despite divergent evolutionary starting points across the genus for these particular drugs. Though drug-selected loci were limited, we do identify novel resistance-imparting mutations. Continuing to explore paths to resistance across different experimental conditions and genomic backgrounds, which could shunt evolution down alternative evolutionary trajectories, will ultimately flesh out the full resistome.IMPORTANCE is a global threat to public health due to its rapid acquisition of antibiotic resistance to all first-line treatments. Recent work has documented that alleles acquired from close commensal relatives have played a large role in the emergence of resistance to macrolides and beta-lactams within gonococcal populations. However, commensals have been relatively underexplored for the resistance genotypes they may harbor. This leaves a gap in our understanding of resistance that could be rapidly acquired by the gonococcus through a known highway of horizontal gene exchange. Here, we characterize resistance mechanisms that can emerge in commensal populations via selection to multiple antimicrobials and begin to define the number of paths to resistance. This study, and other similar works, may ultimately aid both surveillance efforts and clinical diagnostic development by nominating novel and conserved resistance mechanisms that may be at risk of rapid dissemination to pathogen populations.
属内的物种善于共享适应性等位基因变异,共生种反复将耐药性转移给它们的致病性亲缘种。然而,共生种的耐药性特征很少被描述,限制了我们预测新的和潜在可转移的耐药机制的能力,这些机制最终可能在临床上变得很重要。每个物种独特的进化起点都有不同的基因组背景,这可能最终控制进化种群对选择的反应,因为上位性和加性相互作用迫使谱系沿着不同的进化轨迹发展。或者,由于共同的祖先,物种之间存在相似的遗传内容,可能会限制现有的适应性解决方案。因此,确定共生体中的耐药途径可能有助于描述耐药体——即属内等位基因库及其深度。在这里,我们使用四个共生种的进化来研究对两种抗生素——大环内酯类阿奇霉素和β-内酰胺类青霉素——的耐药性进化的潜力和可重复性。经过 20 天的选择,16 个共生体中有 11 个和 12 个分别对青霉素和阿奇霉素产生了耐药性。几乎所有耐药性出现的情况都集中在核糖体成分或阿奇霉素选择的外排泵的突变上,而青霉素选择的则是 、 、 ,这表明尽管属内的进化起点不同,但适应性解决方案受到限制。尽管药物选择的基因座有限,但我们确实发现了新的耐药性赋予突变。继续探索不同实验条件和基因组背景下的耐药途径,这些途径可能会使进化转向替代的进化轨迹,最终将完整的耐药体描绘出来。
由于其对所有一线治疗药物的抗生素耐药性迅速获得,已经成为全球公共卫生的威胁。最近的研究已经证明,来自密切共生亲属的等位基因在淋球菌群体中对大环内酯类和β-内酰胺类药物的耐药性的出现中发挥了很大的作用。然而,共生体的耐药基因型相对未被充分探索。这使得我们对淋球菌可能通过已知的水平基因转移高速公路迅速获得的耐药性存在理解上的差距。在这里,我们通过对多种抗生素的选择来描述共生体种群中可能出现的耐药机制,并开始定义耐药途径的数量。这项研究和其他类似的工作可能最终通过提名可能迅速传播到病原体种群的新的和保守的耐药机制,来帮助监测工作和临床诊断的发展。